Gnubiotics Sciences SA

Private

EpalingesHealthcare & Life Scienceshttps://gnubiotics.com/

Last Round

Grant

Jul 6, 2022

Total Funding Raised

$7.49M

Company Overview

Gnubiotics Sciences SA is a biotechnology company that develops glycan-based solutions and functional ingredients to improve microbiome health in humans and companion animals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Infrastructure

Keywords

microbiome therapeuticsglycan-based therapeuticsfunctional ingredientsgut healthmicrobiome modulationpet gut healthbiotech R&Dpet nutritionbiotech platformdrug discoveryglycopeptide therapeuticsprecision medicinegut health supplementsmicrobiome biomarkersbioinformatics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Gnubiotics Sciences SA Comps

Public and private peers based on sector, stage, and business model.

Gnubiotics Sciences SA comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Gnubiotics Sciences SA Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Jul 6, 2022
Debt	Jul 30, 2020
Series A	Jul 30, 2020
Convertible Debt	Dec 28, 2017
Accelerator	May 29, 2017

View all Funding Rounds

Key People

Founding team and executive leadership

Bernardo Horta e Costa

Co-founder & CFO

Founding Team

Gnubiotics Sciences SA Investors

Notable investors and investment history

Gnubiotics Sciences SA investors
Investor	Rounds
Canton of Vaud	Debt
Innosuisse	Grant
Venture Kick	Accelerator

View all Investors

Gnubiotics Sciences SA Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Gnubiotics Sciences SA Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Gnubiotics Sciences SA's valuation, stock price, and market status.

Firmographic Details

HeadquartersEpalinges

Employee Range5

Year Founded2016

Last FundingJul 6, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.